Literature DB >> 29193837

Weight Change During the Early Rheumatoid Arthritis Period and Risk of Subsequent Mortality in Women With Rheumatoid Arthritis and Matched Comparators.

Jeffrey A Sparks1, Shun-Chiao Chang1, Uyen-Sa Nguyen2, Medha Barbhaiya1, Sara K Tedeschi1, Bing Lu1, David J Kreps1, Karen H Costenbader1, Yuqing Zhang3, Hyon K Choi3, Elizabeth W Karlson1.   

Abstract

OBJECTIVE: To investigate whether weight change during the early rheumatoid arthritis (RA) period is associated with subsequent mortality and to evaluate whether there is an RA-specific effect.
METHODS: We identified patients with incident RA during the Nurses' Health Study (NHS; 1976-2016) and created a comparison cohort by matching each RA patient with up to 10 non-RA comparators by age and calendar year of the RA diagnosis (index date). To capture weight change around the early RA period ("peri-RA/index"), we used weight measurements collected 2-4 years before and 2-4 years after the index date. We used Cox regression analysis to estimate hazard ratios (HRs) for mortality according to peri-RA/index weight change categories, separately in each cohort and in the combined cohorts, evaluating for an RA-specific effect.
RESULTS: Among 121,701 women in the NHS, 902 patients with incident RA were identified and matched to 7,884 non-RA comparators. In the RA cohort, 371 deaths (41.1%) occurred during a mean follow-up of 17.0 years after the early RA period, and 2,303 deaths (29.2%) occurred in the comparison cohort during a mean follow-up of 18.4 years. Weight loss of >30 pounds during the peri-RA period had a hazard ratio (HR) for mortality of 2.78 (95% confidence interval [95% CI] 1.58-4.89) compared to stable weight; results in the comparison cohort were similar (HR 2.16, 95% CI 1.61-2.88). A weight gain of >30 pounds had no association with mortality in patients with RA (HR 1.45, 95% CI 0.69-3.07) or comparators (HR 1.19, 95% CI 0.89-1.59). For mortality, there was no statistically significant interaction between RA/comparator status and weight change category (P = 0.68).
CONCLUSION: Severe weight loss during the early RA period was associated with an increased subsequent mortality risk for women with and those without RA. These results extend prior observations by including non-RA comparators and finding no protective association between weight gain and mortality, providing evidence against an RA-specific obesity paradox for mortality.
© 2017, American College of Rheumatology.

Entities:  

Mesh:

Year:  2017        PMID: 29193837      PMCID: PMC5745282          DOI: 10.1002/art.40346

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  42 in total

Review 1.  Rheumatoid cachexia and cardiovascular disease.

Authors:  Gregory D Summers; Giorgos S Metsios; Antonios Stavropoulos-Kalinoglou; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2010-07-20       Impact factor: 20.543

2.  Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study.

Authors:  Tim Bongartz; Carlotta Nannini; Yimy F Medina-Velasquez; Sara J Achenbach; Cynthia S Crowson; Jay H Ryu; Robert Vassallo; Sherine E Gabriel; Eric L Matteson
Journal:  Arthritis Rheum       Date:  2010-06

3.  Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation.

Authors:  Agustín Escalante; Roy W Haas; Inmaculada del Rincón
Journal:  Arch Intern Med       Date:  2005-07-25

4.  Mortality in rheumatoid arthritis: relationship to single and composite measures of disease activity.

Authors:  J C Chehata; A B Hassell; S A Clarke; D L Mattey; M A Jones; P W Jones; P T Dawes
Journal:  Rheumatology (Oxford)       Date:  2001-04       Impact factor: 7.580

5.  Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registry.

Authors:  Ted R Mikuls; Brian T Fay; Kaleb Michaud; Harlan Sayles; Geoffrey M Thiele; Liron Caplan; Dannette Johnson; John S Richards; Gail S Kerr; Grant W Cannon; Andreas Reimold
Journal:  Rheumatology (Oxford)       Date:  2010-07-21       Impact factor: 7.580

6.  Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis.

Authors:  Hilal Maradit Kremers; Paulo J Nicola; Cynthia S Crowson; Karla V Ballman; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2004-11

7.  Underweight and obese states both associate with worse disease activity and physical function in patients with established rheumatoid arthritis.

Authors:  Antonios Stavropoulos-Kalinoglou; Giorgos S Metsios; Vasileios F Panoulas; Alan M Nevill; Athanasios Z Jamurtas; Yiannis Koutedakis; George D Kitas
Journal:  Clin Rheumatol       Date:  2008-12-19       Impact factor: 2.980

8.  The widening mortality gap between rheumatoid arthritis patients and the general population.

Authors:  Angel Gonzalez; Hilal Maradit Kremers; Cynthia S Crowson; Paulo J Nicola; John M Davis; Terry M Therneau; Veronique L Roger; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2007-11

9.  Mortality trends in rheumatoid arthritis: the role of rheumatoid factor.

Authors:  Angel Gonzalez; Murat Icen; Hilal Maradit Kremers; Cynthia S Crowson; John M Davis; Terry M Therneau; Veronique L Roger; Sherine E Gabriel
Journal:  J Rheumatol       Date:  2008-04-15       Impact factor: 4.666

10.  Body mass index, weight change, and death in older adults: the systolic hypertension in the elderly program.

Authors:  Grant W Somes; Stephen B Kritchevsky; Ronald I Shorr; Marco Pahor; William B Applegate
Journal:  Am J Epidemiol       Date:  2002-07-15       Impact factor: 4.897

View more
  3 in total

1.  Dynamics of body mass index and visceral adiposity index in patients with rheumatoid arthritis treated with tofacitinib.

Authors:  Diana S Novikova; Helen V Udachkina; Eugenia I Markelova; Irina G Kirillova; Anna S Misiyuk; Natalia V Demidova; Tatiana V Popkova
Journal:  Rheumatol Int       Date:  2019-05-03       Impact factor: 2.631

Review 2.  The Incidence and Pathophysiology of the Obesity Paradox: Should Peritoneal Dialysis and Kidney Transplant Be Offered to Patients with Obesity and End-Stage Renal Disease?

Authors:  Ramzi Vareldzis; Mihran Naljayan; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2018-07-26       Impact factor: 4.592

Review 3.  Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.

Authors:  James M Gwinnutt; Maud Wieczorek; Giulio Cavalli; Andra Balanescu; Heike A Bischoff-Ferrari; Annelies Boonen; Savia de Souza; Annette de Thurah; Thomas E Dorner; Rikke Helene Moe; Polina Putrik; Javier Rodríguez-Carrio; Lucía Silva-Fernández; Tanja Stamm; Karen Walker-Bone; Joep Welling; Mirjana I Zlatković-Švenda; Francis Guillemin; Suzanne M M Verstappen
Journal:  RMD Open       Date:  2022-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.